Kristen L. Veraldi

Kristen Veraldi practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Kristen Veraldi's NPI, 1164578746, was assigned on January 26, 2007. Kristen Veraldi graduated from University of Pittsburgh School of Medicine in 2001. Kristen Veraldi holds Pennsylvania license MD432337.

Kristen Veraldi's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Kristen Veraldi's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Kristen Veraldi is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Kristen Veraldi to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kristen Veraldi practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Kristen Veraldi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Kristen Veraldi is licensed in Pennsylvania.

CMS data shows 32 Medicare services from Kristen Veraldi across 2 procedure codes in 2024, for 16 Medicare patients. Medicare paid $1,403 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 16 Medicare patients who saw Kristen Veraldi in 2024. 75% of them have high cholesterol. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kristen Veraldi's median patient age at 70, with 68% women.

In 2024, Kristen Veraldi wrote 138 Medicare Part D claims for 20 patients. 48% of them were for generic drugs. CMS names the drug for 101 of them, across 6 drugs with 11 or more claims each, at $346,596 in total drug cost. In 2023, CMS named 84 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Kristen Veraldi for performance year 2024, reported as part of a group. Kristen Veraldi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kristen Veraldi as offering telehealth.

Dmand AI links 10 papers to Kristen Veraldi, published from 2012 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Idiopathic Pulmonary Fibrosis, Lung and Bleomycin. Kristen Veraldi has published most often in Open Rheumatol J. Kristen Veraldi's most frequent co-authors are Daniel Jeremy Kass, MD, Joseph M. Pilewski and Humberto Enrique Trejo Bittar, MD.

Dmand AI links Kristen Veraldi to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis and Death. University of Pittsburgh sponsors the most, 2.

Kristen Veraldi graduated from University of Pittsburgh School of Medicine in 2001.